Details of Drug

Drug General Information (ID: D1230)
Drug Name	Pasireotide
Drug Type	Small molecule
Drug Synonymous	Signifor; UNII-I4P76SY3N4; Pasireotide diaspartate; I4P76SY3N4; SOM230; 820232-50-6; pasireotide aspartate; Pasireotide diaspartate [EMA EPAR]; CHEBI:72313; Cyclo((2R)-2-phenylglycyl-d-tryptophyl-l-lysyl-o-(phenylmethyl)-l-tyrosyl-l-phenylalanyl-(4R)-4-((((2-aminoethyl)amino)carbonyl)oxy)-l-prolyl), l-aspartate; Signifor (TN); SOM 230; SOM-230 Click to Show/Hide
Disease Class	5A70: Cushing syndrome
Therapeutic Class	Somatostatin/Somatostatin Analogs
Structure
Structure	3D Structure		2D Structure
Formula	C58H66N10O9
InChI	1S/C58H66N10O9/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72)/t43-,46+,47+,48-,49+,50+,51+/m1/s1
InChIKey	VMZMNAABQBOLAK-DBILLSOUSA-N
Canonical SMILES	C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN
External Link
	Pubchem ID	9941444
	CAS Number	396091-73-9
	CHEBI ID	72312
	TTD ID	D0TV0C

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM003 Affected organization distribution AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM009 Altered absorption (Unspecific) BM014 Interference of cell/tissue uptake BM017 CYP450 enzyme inhibition BM049 Increased risk of atrioventricular block BM051 Increased risk of bradycardia BM055 Increased risk of hepatotoxicity BM064 Increased risk of hypoglycemia BM076 Increased risk of prolong QT interval BM081 Increased risk of ventricular arrhythmias BM086 Antagonize the effect of antidiabetic agents BM089 Antagonize the effect of antihypertensive agents
Relation Graph

Full list of drugs interacting with Pasireotide
Affected gastrointestinal absorption
	Altered absorption (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0402		Cyclosporine	C62H111N11O12	5284373	Moderate		Inter Info	[203], [204], [4], [177]
Affected organization distribution
	Interference of cell/tissue uptake					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0391		Copper oxodotreotide Cu-64	NA	NA	Major		Inter Info	[120]
D1778		Dotatate	C65H90N14O19S2	11170867	Moderate		Inter Info	[251]
D0964		Lutetium Lu 177 dotatate	C65H87LuN14O19S2	76966897	Moderate		Inter Info	[260]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 22
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Major		Inter Info	[105]
D0212		Bromocriptine	C32H40BrN5O5	31101	Moderate		Inter Info	[200], [201], [176], [4], [177]
D0494		Dihydroergotamine	C33H37N5O5	10531	Moderate		Inter Info	[205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229]
D0592		Ergometrine	C19H23N3O2	443884	Moderate		Inter Info	[212], [214], [225]
D0593		Ergotamine	C33H35N5O5	8223	Moderate		Inter Info	[205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229]
D0629		Everolimus	C53H83NO14	6442177	Moderate		Inter Info	[232], [233]
D1043		Methysergide	C21H27N3O2	9681	Moderate		Inter Info	[212], [214], [225]
D1203		Oxycodone	C18H21NO4	5284603	Moderate		Inter Info	[2], [3], [247]
D0008		Acalabrutinib	C26H23N7O2	71226662	Moderate		Inter Info	[248], [233]
D0129		Avapritinib	C26H27FN10	118023034	Moderate		Inter Info	[3], [249]
D0543		Duvelisib	C22H17ClN6O	50905713	Moderate		Inter Info	[252]
D0785		Ibrutinib	C25H24N6O2	24821094	Moderate		Inter Info	[253], [233]
D0866		Istradefylline	C20H24N4O4	5311037	Moderate		Inter Info	[255]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Moderate		Inter Info	[2], [3], [256]
D0953		Lorlatinib	C21H19FN6O2	71731823	Moderate		Inter Info	[257]
D0961		Lurasidone	C28H36N4O2S	213046	Moderate		Inter Info	[2], [3], [258], [233]
D0962		Lurbinectedin	C41H44N4O10S	57327016	Moderate		Inter Info	[259]
D1324		Pralsetinib	C27H32FN9O2	129073603	Moderate		Inter Info	[263]
D1409		Ripretinib	C24H21BrFN5O2	71584930	Moderate		Inter Info	[2], [267]
D1666		Upadacitinib	C17H19F3N6O	58557659	Moderate		Inter Info	[268]
D0425		Darolutamide	C19H19ClN6O2	67171867	Minor		Inter Info	[286]
D0518		Doravirine	C17H11ClF3N5O3	58460047	Minor		Inter Info	[287]
Pharmacodynamic additive effects
	Increased risk of bradycardia					Drug Num: 37
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0010		Acebutolol	C18H28N2O4	1978	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0069		Amlodipine	C20H25ClN2O5	2162	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0116		Atazanavir	C38H52N6O7	148192	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0117		Atenolol	C14H22N2O3	2249	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0173		Betaxolol	C18H29NO3	2369	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0174		Betaxolol (ophthalmic)	C18H29NO3	2369	Moderate		Inter Info	[1], [2], [179]
D0188		Bisoprolol	C18H31NO4	2405	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0265		Carteolol	C16H24N2O3	2583	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0266		Carteolol (ophthalmic)	C16H24N2O3	2583	Moderate		Inter Info	[1], [2], [179]
D0267		Carvedilol	C24H26N2O4	2585	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0352		Clevidipine	C21H23Cl2NO6	153994	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0490		Digitoxin	C41H64O13	441207	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0491		Digoxin	C41H64O14	2724385	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0602		Esmolol	C16H25NO4	59768	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0865		Isradipine	C19H21N3O5	3784	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0884		Labetalol	C19H24N2O3	3869	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0885		Lacosamide	C13H18N2O3	219078	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0915		Levobunolol (ophthalmic)	C17H25NO3	39468	Moderate		Inter Info	[1], [2], [179]
D0927		Lidocaine	C14H22N2O	3676	Moderate		Inter Info	[1], [2], [3], [179], [4]
D1045		Metipranolol (ophthalmic)	C17H27NO4	31477	Moderate		Inter Info	[1], [2], [179]
D1049		Metoprolol	C15H25NO3	4171	Moderate		Inter Info	[1], [2], [3], [179], [4]
D1088		Moricizine	C22H25N3O4S	34633	Moderate		Inter Info	[1], [2], [3], [179], [4]
D1098		Nadolol	C17H27NO4	39147	Moderate		Inter Info	[1], [2], [3], [179], [4]
D1114		Nebivolol	C22H25F2NO4	71301	Moderate		Inter Info	[1], [2], [3], [179], [4]
D1130		Nicardipine	C26H29N3O6	4474	Moderate		Inter Info	[1], [2], [3], [179], [4]
D1138		Nimodipine	C21H26N2O7	4497	Moderate		Inter Info	[1], [2], [3], [179], [4]
D1141		Nisoldipine	C20H24N2O6	4499	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0911		Levamlodipine	C20H25ClN2O5	9822750	Moderate		Inter Info	[1], [2], [3], [179], [4]
D0914		Levobetaxolol (ophthalmic)	C18H29NO3	60657	Moderate		Inter Info	[1], [2], [179]
D1244		Penbutolol	C18H29NO2	37464	Moderate		Inter Info	[1], [2], [3], [179], [4]
D1293		Pindolol	C14H20N2O2	4828	Moderate		Inter Info	[1], [2], [3], [179], [4]
D1357		Propranolol	C16H21NO2	4946	Moderate		Inter Info	[1], [2], [3], [179], [4]
D1418		Rivastigmine	C14H22N2O2	77991	Moderate		Inter Info	[1], [2], [3], [179], [4]
D1585		Timolol	C13H24N4O3S	33624	Moderate		Inter Info	[1], [2], [3], [179], [4]
D1586		Timolol (ophthalmic)	C13H24N4O3S	33624	Moderate		Inter Info	[1], [2], [179]
D1690		Verapamil	C27H38N2O4	2520	Moderate		Inter Info	[1], [2], [3], [179], [4]
	Increased risk of hepatotoxicity					Drug Num: 19
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[1], [102], [103]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[108]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[125]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[129]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[1], [102], [103]
D0114		Asparaginase Escherichia coli	NA	NA	Moderate		Inter Info	[189], [190], [191], [2], [3], [192], [193], [194], [195], [196], [197], [198], [199]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[202]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[235], [236], [237], [238]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[3], [244]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[245]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[189], [190], [191], [2], [3], [192], [193], [194], [195], [196], [197], [198], [199]
D0232		Calaspargase pegol	NA	NA	Moderate		Inter Info	[189], [190], [191], [2], [3], [192], [193], [194], [195], [196], [197], [198], [199]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[3], [250]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[254]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[235], [236], [237], [238]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[2], [3], [264], [265], [266]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[189], [190], [191], [2], [3], [192], [193], [194], [195], [196], [197], [198], [199]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[280], [281]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[3], [282]
	Increased risk of prolong QT interval					Drug Num: 175
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0003		Abarelix	C72H95ClN14O14	16131215	Major		Inter Info	[1], [2], [3], [4]
D0007		Abiraterone	C24H31NO	132971	Major		Inter Info	[1], [2], [3], [4]
D0036		Alfuzosin	C19H27N5O4	2092	Major		Inter Info	[1], [2], [3], [4]
D0037		Alimemazine	C18H22N2S	5574	Major		Inter Info	[2], [3], [4]
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[1], [2], [3], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21]
D0072		Amoxapine	C17H16ClN3O	2170	Major		Inter Info	[1], [2], [3], [4]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[1], [2], [3], [23]
D0097		Apomorphine	C17H17NO2	6005	Major		Inter Info	[1], [2], [3], [4]
D0112		Asenapine	C17H16ClNO	3036780	Major		Inter Info	[1], [2], [3], [4]
D0115		Astemizole	C28H31FN4O	2247	Major		Inter Info	[1], [2], [3], [4]
D0119		Atomoxetine	C17H21NO	54841	Major		Inter Info	[1], [2], [3], [4]
D0139		Azithromycin	C38H72N2O12	447043	Major		Inter Info	[1], [2], [3], [4]
D0170		Bepridil	C24H34N2O	2351	Major		Inter Info	[1], [2], [3], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21]
D0180		Bicalutamide	C18H14F4N2O4S	2375	Major		Inter Info	[1], [2], [3], [4]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Major		Inter Info	[1], [2], [3], [4]
D0219		Buprenorphine	C29H41NO4	644073	Major		Inter Info	[1], [2], [3], [4]
D0320		Chloroquine	C18H26ClN3	2719	Major		Inter Info	[26], [3], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44]
D0324		Chlorpromazine	C17H19ClN2S	2726	Major		Inter Info	[1], [2], [3], [4]
D0336		Cilostazol	C20H27N5O2	2754	Major		Inter Info	[1], [2], [3], [4]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Major		Inter Info	[1], [2], [3], [4]
D0342		Cisapride	C23H29ClFN3O4	6917698	Major		Inter Info	[1], [2], [3], [9], [45], [46]
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[1], [2], [3], [47], [48], [21], [49]
D0349		Clarithromycin	C38H69NO13	84029	Major		Inter Info	[1], [2], [3], [4]
D0358		Clofazimine	C27H22Cl2N4	2794	Major		Inter Info	[1], [2], [3], [4]
D0361		Clomipramine	C19H23ClN2	2801	Major		Inter Info	[1], [2], [3], [4]
D0370		Clozapine	C18H19ClN4	135398737	Major		Inter Info	[1], [2], [3], [50], [21]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Major		Inter Info	[1], [2], [3], [4]
D0429		Daunorubicin	C27H29NO10	30323	Major		Inter Info	[1], [2], [3], [4]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Major		Inter Info	[2], [3], [4]
D0446		Desipramine	C18H22N2	2995	Major		Inter Info	[1], [2], [3], [4]
D0467		Dextropropoxyphene	C22H29NO2	10100	Major		Inter Info	[2], [3], [4]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[1], [2], [3], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21]
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[1], [2], [3], [51]
D0514		Dolasetron	C19H20N2O3	3033818	Major		Inter Info	[1], [2], [3], [4]
D0525		Doxepin	C19H21NO	667477	Major		Inter Info	[1], [2], [3], [4]
D0526		Doxepin (topical)	C19H21NO	667477	Major		Inter Info	[2], [3], [4]
D0528		Doxorubicin	C27H29NO11	31703	Major		Inter Info	[1], [2], [3], [4]
D0529		Doxorubicin (liposomal)	C27H29NO11	31703	Major		Inter Info	[2], [3], [4]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[1], [2], [3], [52]
D0535		Droperidol	C22H22FN3O2	3168	Major		Inter Info	[1], [2], [3], [53], [54], [21]
D0554		Efavirenz	C14H9ClF3NO2	64139	Major		Inter Info	[55]
D0584		Epirubicin	C27H29NO11	41867	Major		Inter Info	[1], [2], [3], [4]
D0597		Erythromycin	C37H67NO13	12560	Major		Inter Info	[1], [2], [3], [4]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[1], [56], [2], [3], [57], [58], [21]
D0632		Ezogabine	C16H18FN3O2	121892	Major		Inter Info	[1], [2], [3], [4]
D0664		Flecainide	C17H20F6N2O3	3356	Major		Inter Info	[1], [2], [3], [4]
D0667		Fluconazole	C13H12F2N6O	3365	Major		Inter Info	[1], [2], [3], [4]
D0676		Fluoxetine	C17H18F3NO	3386	Major		Inter Info	[1], [2], [3], [4]
D0678		Fluphenazine	C22H26F3N3OS	3372	Major		Inter Info	[1], [2], [3], [4]
D0682		Flutamide	C11H11F3N2O3	3397	Major		Inter Info	[1], [2], [3], [4]
D0694		Foscarnet	CH3O5P	3415	Major		Inter Info	[1], [2], [3], [4]
D0712		Gatifloxacin	C19H22FN3O4	5379	Major		Inter Info	[59], [60], [61], [1], [2], [3], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Major		Inter Info	[1], [2], [3], [4]
D0737		Goserelin	C59H84N18O14	5311128	Major		Inter Info	[1], [2], [3], [4]
D0738		Granisetron	C18H24N4O	5284566	Major		Inter Info	[1], [2], [3], [4]
D0740		Grepafloxacin	C19H22FN3O3	72474	Major		Inter Info	[60], [1], [2], [3], [82], [83], [84]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Major		Inter Info	[85], [1], [2], [3], [86], [87], [88], [89], [90]
D0750		Haloperidol	C21H23ClFNO2	3559	Major		Inter Info	[1], [2], [3], [91], [92], [93], [94], [95], [96], [21]
D0751		Halothane	C2HBrClF3	3562	Major		Inter Info	[1], [2], [3], [4]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Major		Inter Info	[26], [3], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Major		Inter Info	[1], [2], [3], [4]
D0787		Ibutilide	C20H36N2O3S	60753	Major		Inter Info	[1], [2], [3], [97]
D0788		Idarubicin	C26H27NO9	42890	Major		Inter Info	[1], [2], [3], [4]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[1], [2], [3], [98], [21]
D0795		Imipramine	C19H24N2	3696	Major		Inter Info	[1], [2], [3], [4]
D0806		Inotuzumab ozogamicin	NA	NA	Major		Inter Info	[1], [2], [3], [4]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Major		Inter Info	[1], [2], [3], [4]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Major		Inter Info	[1], [2], [3], [4]
D0908		Leuprolide	C59H84N16O12	657181	Major		Inter Info	[1], [2], [3], [4]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[3], [104], [21]
D0919		Levofloxacin	C18H20FN3O4	149096	Major		Inter Info	[1], [2], [3], [4]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Major		Inter Info	[1], [2], [3], [4]
D0942		Lofexidine	C11H12Cl2N2O	30668	Major		Inter Info	[1], [2], [3], [4]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Major		Inter Info	[1], [2], [3], [4]
D0948		Lopinavir	C37H48N4O5	92727	Major		Inter Info	[2], [3], [4]
D0979		Maprotiline	C20H23N	4011	Major		Inter Info	[1], [2], [3], [4]
D0992		Mefloquine	C17H16F6N2O	4046	Major		Inter Info	[1], [2], [3], [4]
D1010		Mesoridazine	C21H26N2OS2	4078	Major		Inter Info	[1], [2], [3], [106], [21]
D1017		Methadone	C21H27NO	4095	Major		Inter Info	[1], [2], [3], [4]
D1026		Methotrimeprazine	C19H24N2OS	72287	Major		Inter Info	[1], [2], [3], [4]
D1062		Midostaurin	C35H30N4O4	9829523	Major		Inter Info	[1], [2], [3], [4]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[1], [2], [3], [107]
D1075		Mirtazapine	C17H19N3	4205	Major		Inter Info	[1], [2], [3], [4]
D1092		Moxifloxacin	C21H24FN3O4	152946	Major		Inter Info	[59], [60], [61], [1], [2], [3], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81]
D1136		Nilotinib	C28H22F3N7O	644241	Major		Inter Info	[1], [2], [3], [109]
D1137		Nilutamide	C12H10F3N3O4	4493	Major		Inter Info	[1], [2], [3], [4]
D1155		Norfloxacin	C16H18FN3O3	4539	Major		Inter Info	[1], [2], [3], [4]
D1158		Nortriptyline	C19H21N	4543	Major		Inter Info	[1], [2], [3], [4]
D1165		Ofloxacin	C18H20FN3O4	4583	Major		Inter Info	[1], [2], [3], [4]
D1181		Ondansetron	C18H19N3O	4595	Major		Inter Info	[1], [2], [3], [4]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Major		Inter Info	[1], [2], [3], [4]
D1210		Oxytocin	C43H66N12O12S2	439302	Major		Inter Info	[1], [2], [3], [4]
D1215		Paliperidone	C23H27FN4O3	115237	Major		Inter Info	[1], [2], [3], [4]
D1216		Palonosetron	C19H24N2O	6337614	Major		Inter Info	[1], [2], [3], [4]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[110]
D1223		Papaverine	C20H21NO4	4680	Major		Inter Info	[111], [112], [113], [114], [115], [116], [117], [118]
D0095		Apalutamide	C21H15F4N5O2S	24872560	Major		Inter Info	[1], [2], [3], [4]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Major		Inter Info	[1], [2], [3], [4]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[1], [2], [3], [4]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[1], [2], [3], [119]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[1], [2], [3], [4]
D0452		Deutetrabenazine	C19H27NO3	73437646	Major		Inter Info	[1], [2], [3], [4]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Major		Inter Info	[1], [2], [3], [4]
D0577		Entrectinib	C31H34F2N6O2	25141092	Major		Inter Info	[1], [2], [3], [4]
D0594		Eribulin	C40H59NO11	11354606	Major		Inter Info	[1], [2], [3], [4]
D0700		Fostemsavir	C25H26N7O8P	11319217	Major		Inter Info	[1], [2], [3], [4]
D0720		Gilteritinib	C29H44N8O3	49803313	Major		Inter Info	[1], [2], [3], [4]
D0725		Glasdegib	C21H22N6O	25166913	Major		Inter Info	[1], [2], [3], [4]
D0758		Histrelin	C66H86N18O12	25077993	Major		Inter Info	[1], [2], [3], [4]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[124]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Major		Inter Info	[1], [2], [3], [4]
D0940		Lithium carbonate	CLi2O3	11125	Major		Inter Info	[2], [3], [4]
D0965		Macimorelin	C26H30N6O3	9804938	Major		Inter Info	[126]
D1169		Oliceridine	C22H30N2O2S	66553195	Major		Inter Info	[127]
D1189		Osilodrostat	C13H10FN3	44139752	Major		Inter Info	[1], [2], [3], [4]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[1], [2], [3], [4]
D1302		Pitolisant	C17H26ClNO	9948102	Major		Inter Info	[1], [2], [3], [4]
D1388		Relugolix	C29H27F2N7O5S	10348973	Major		Inter Info	[1], [2], [3], [4]
D1404		Rilpivirine	C22H18N6	6451164	Major		Inter Info	[1], [2], [3], [4]
D1432		Rucaparib	C19H18FN3O	9931954	Major		Inter Info	[1], [2], [3], [4]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[3], [130]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Major		Inter Info	[1], [2], [3], [4]
D1651		Triptorelin	C64H82N18O13	25074470	Major		Inter Info	[1], [2], [3], [4]
D1673		Valbenazine	C24H38N2O4	24795069	Major		Inter Info	[1], [2], [3], [4]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Major		Inter Info	[1], [2], [3], [132]
D1232		Pazopanib	C21H23N7O2S	10113978	Major		Inter Info	[1], [2], [3], [4]
D1246		Pentamidine	C19H24N4O2	4735	Major		Inter Info	[1], [2], [3], [4]
D1254		Perflutren	C3F8	6432	Major		Inter Info	[133], [134]
D1257		Perphenazine	C21H26ClN3OS	4748	Major		Inter Info	[1], [2], [3], [4]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[3], [53], [135], [21]
D1315		Posaconazole	C37H42F2N8O4	468595	Major		Inter Info	[1], [2], [3], [4]
D1339		Primaquine	C15H21N3O	4908	Major		Inter Info	[1], [2], [3], [4]
D1343		Procainamide	C13H21N3O	4913	Major		Inter Info	[1], [2], [3], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21]
D1346		Prochlorperazine	C20H24ClN3S	4917	Major		Inter Info	[1], [2], [3], [4]
D1351		Promazine	C17H20N2S	4926	Major		Inter Info	[1], [2], [3], [4]
D1352		Promethazine	C17H20N2S	4927	Major		Inter Info	[1], [2], [3], [4]
D1353		Propafenone	C21H27NO3	4932	Major		Inter Info	[1], [2], [3], [4]
D1361		Protriptyline	C19H21N	4976	Major		Inter Info	[1], [2], [3], [4]
D1368		Quetiapine	C21H25N3O2S	5002	Major		Inter Info	[1], [2], [3], [4]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[1], [2], [3], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21]
D1372		Quinine	C20H24N2O2	3034034	Major		Inter Info	[1], [2], [3], [4]
D1383		Ranolazine	C24H33N3O4	56959	Major		Inter Info	[1], [2], [3], [4]
D1424		Romidepsin	C24H36N4O6S2	5352062	Major		Inter Info	[1], [2], [3], [4]
D1444		Saquinavir	C38H50N6O5	441243	Major		Inter Info	[160], [161], [1], [2], [3], [162], [163]
D1463		Sevoflurane	C4H3F7O	5206	Major		Inter Info	[1], [2], [3], [4]
D1491		Solifenacin	C23H26N2O2	154059	Major		Inter Info	[1], [2], [3], [4]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Major		Inter Info	[1], [2], [3], [4]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[1], [2], [3], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Major		Inter Info	[60], [1], [2], [3], [164], [165], [64], [66], [68], [166], [69], [70], [167], [72], [73], [74], [75], [168], [79], [84], [169]
D1522		Sunitinib	C22H27FN4O2	5329102	Major		Inter Info	[1], [2], [3], [4]
D1526		Tacrolimus	C44H69NO12	445643	Major		Inter Info	[1], [2], [3], [4]
D1533		Tamoxifen	C26H29NO	2733526	Major		Inter Info	[1], [2], [3], [4]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Major		Inter Info	[1], [2], [3], [4]
D1544		Telithromycin	C43H65N5O10	3002190	Major		Inter Info	[1], [2], [3], [4]
D1555		Terfenadine	C32H41NO2	5405	Major		Inter Info	[1], [2], [3], [4]
D1560		Tetrabenazine	C19H27NO3	6018	Major		Inter Info	[1], [2], [3], [4]
D1574		Thioridazine	C21H26N2S2	5452	Major		Inter Info	[1], [2], [3], [170], [53], [171], [172], [173], [21]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[1], [2], [3], [174]
D1616		Tramadol	C16H25NO2	33741	Major		Inter Info	[1], [2], [3], [4]
D1624		Trazodone	C19H22ClN5O	5533	Major		Inter Info	[1], [2], [3], [4]
D1637		Trifluoperazine	C21H24F3N3S	5566	Major		Inter Info	[1], [2], [3], [4]
D1638		Triflupromazine	C18H19F3N2S	5568	Major		Inter Info	[1], [2], [3], [4]
D1647		Trimipramine	C20H26N2	5584	Major		Inter Info	[1], [2], [3], [4]
D1682		Vardenafil	C23H32N6O4S	135400189	Major		Inter Info	[1], [2], [3], [4]
D1683		Vasopressin	C46H65N15O12S2	644077	Major		Inter Info	[1], [2], [3], [4]
D1689		Venlafaxine	C17H27NO2	5656	Major		Inter Info	[1], [2], [3], [4]
D1706		Voriconazole	C16H14F3N5O	71616	Major		Inter Info	[1], [2], [3], [4]
D1726		Ziprasidone	C21H21ClN4OS	60854	Major		Inter Info	[1], [2], [3], [53], [175], [21]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[2], [3], [183], [184], [185], [186], [187], [188]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[2], [3], [234]
D0947		Loperamide	C29H33ClN2O2	3955	Moderate		Inter Info	[242], [243]
D1166		Olanzapine	C17H20N4S	135398745	Moderate		Inter Info	[2], [3], [246]
D1356		Propofol	C12H18O	4943	Moderate		Inter Info	[269], [270], [271], [272], [273], [274], [275], [276], [277], [278]
D1051		Metronidazole	C6H9N3O3	4173	Minor		Inter Info	[2], [283], [284], [285]
D1516		Sulfamethoxazole	C10H11N3O3S	5329	Minor		Inter Info	[1], [2], [3], [288], [289], [290], [291]
	Increased risk of ventricular arrhythmias					Drug Num: 38
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0025		Adenosine	C10H13N5O4	60961	Major		Inter Info	[5], [3], [6], [7], [8], [9], [10], [11]
D0067		Amisulpride	C17H27N3O4S	2159	Major		Inter Info	[22]
D0107		Arsenic trioxide	As2O3	14888	Major		Inter Info	[24], [25]
D0859		Isoprenaline	C11H17NO3	3779	Major		Inter Info	[99], [100], [101]
D1185		Orciprenaline	C11H17NO3	4086	Major		Inter Info	[99], [100], [101]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[1], [2], [3], [121], [49]
D0868		Ivabradine	C27H36N2O5	132999	Major		Inter Info	[3], [122], [123]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[128]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[2], [131]
D1414		Ritodrine	C17H21NO3	33572	Major		Inter Info	[99], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [153], [100], [154], [155], [156], [157], [101], [158], [159]
D1554		Terbutaline	C12H19NO3	5403	Major		Inter Info	[99], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [153], [100], [154], [155], [156], [157], [101], [158], [159]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[99], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [180], [181], [148], [149], [150], [151], [152], [182], [153], [100], [154], [155], [156], [157], [101], [158], [159]
D0516		Donepezil	C24H29NO3	3152	Moderate		Inter Info	[1], [2], [3], [230], [179], [231]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[99], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [180], [181], [148], [149], [150], [151], [152], [182], [153], [100], [154], [155], [156], [157], [101], [158], [159]
D0707		Galantamine	C17H21NO3	9651	Moderate		Inter Info	[1], [2], [3], [230], [179], [231]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[99], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [180], [181], [148], [149], [150], [151], [152], [182], [153], [100], [154], [155], [156], [157], [101], [158], [159]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[99], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [180], [181], [148], [149], [150], [151], [152], [182], [153], [100], [154], [155], [156], [157], [101], [158], [159]
D0888		Lactulose	C12H22O11	11333	Moderate		Inter Info	[1], [2], [3], [239], [240], [241]
D0184		Bisacodyl	C22H19NO4	2391	Moderate		Inter Info	[1], [2], [3], [239], [240], [241]
D0269		Castor oil	C57H104O9	14030006	Moderate		Inter Info	[1], [2], [3], [239], [240], [241]
D0701		Frangula purshiana bark	NA	NA	Moderate		Inter Info	[2], [3], [241]
D0731		Glycerin	C3H8O3	753	Moderate		Inter Info	[1], [2], [3], [239], [240], [241]
D0887		Lactitol	C12H24O11	157355	Moderate		Inter Info	[1], [2], [3], [239], [240], [241]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[180], [154], [157]
D0970		Magnesium citrate	C12H10Mg3O14	6099959	Moderate		Inter Info	[1], [2], [3], [239], [240], [241]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[1], [2], [3], [239], [240], [241]
D1069		Mineral oil	NA	NA	Moderate		Inter Info	[1], [2], [3], [239], [240], [241]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[99], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [180], [181], [148], [149], [150], [151], [152], [182], [153], [100], [154], [155], [156], [157], [101], [158], [159]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[3], [261], [262]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[3], [261], [262]
D1309		Polyethylene glycol (3350)	C2H6O2	174	Moderate		Inter Info	[2], [3], [241]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[3], [261], [262]
D1266		Phenolphthalein	C20H14O4	4764	Moderate		Inter Info	[1], [2], [3], [239], [240], [241]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[99], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [180], [181], [148], [149], [150], [151], [152], [182], [153], [100], [154], [155], [156], [157], [101], [158], [159]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[140], [146], [151]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[99], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [180], [181], [148], [149], [150], [151], [152], [182], [153], [100], [154], [155], [156], [157], [101], [158], [159]
D1525		Tacrine	C13H14N2	1935	Moderate		Inter Info	[1], [2], [3], [230], [179], [231]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[2], [3], [279]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antidiabetic agents					Drug Num: 37
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0009		Acarbose	C25H43NO18	41774	Moderate		Inter Info	[176], [177], [178]
D0013		Acetohexamide	C15H20N2O4S	1989	Moderate		Inter Info	[176], [177], [178]
D0042		Alogliptin	C18H21N5O2	11450633	Moderate		Inter Info	[176], [177], [178]
D0325		Chlorpropamide	C10H13ClN2O3S	2727	Moderate		Inter Info	[176], [177], [178]
D0418		Dapagliflozin	C21H25ClO6	9887712	Moderate		Inter Info	[176], [177], [178]
D1784		Exenatide	C184H282N50O60S	45588096	Moderate		Inter Info	[176], [177], [178]
D0727		Glimepiride	C24H34N4O5S	3476	Moderate		Inter Info	[176], [177], [178]
D0728		Glipizide	C21H27N5O4S	3478	Moderate		Inter Info	[176], [177], [178]
D0730		Glyburide	C23H28ClN3O5S	3488	Moderate		Inter Info	[176], [177], [178]
D0807		Insulin aspart (aspart protamine)	C256H381N65O79S6	118984445	Moderate		Inter Info	[176], [177], [178]
D0810		Insulin detemir	C267H402N64O76S6	16137271	Moderate		Inter Info	[176], [177], [178]
D0811		Insulin glargine	C267H404N72O78S6	118984454	Moderate		Inter Info	[176], [177], [178]
D0812		Insulin glulisine	C258H384N64O78S6	16136701	Moderate		Inter Info	[176], [177], [178]
D0813		Insulin human	C257H383N65O77S6	118984375	Moderate		Inter Info	[176], [177], [178]
D0814		Insulin human (inhalation, rapid acting)	C257H383N65O77S6	118984375	Moderate		Inter Info	[176], [177], [178]
D0816		Insulin human (regular)	C257H383N65O77S6	118984375	Moderate		Inter Info	[176], [177], [178]
D0817		Insulin human (zinc extended)	C257H383N65O77S6	118984375	Moderate		Inter Info	[176], [177], [178]
D0818		Insulin human (zinc)	C257H383N65O77S6	118984375	Moderate		Inter Info	[176], [177], [178]
D0819		Insulin lispro	C257H389N65O77S6	16132438	Moderate		Inter Info	[176], [177], [178]
D0820		Insulin lispro (protamine)	C257H389N65O77S6	16132438	Moderate		Inter Info	[176], [177], [178]
D0936		Liraglutide	C172H265N43O51	16134956	Moderate		Inter Info	[176], [177], [178]
D1064		Miglitol	C8H17NO5	441314	Moderate		Inter Info	[176], [177], [178]
D1112		Nateglinide	C19H27NO3	5311309	Moderate		Inter Info	[176], [177], [178]
D0029		Albiglutide	C148H224N40O45	145994868	Moderate		Inter Info	[176], [177], [178]
D0245		Canagliflozin	C24H25FO5S	24812758	Moderate		Inter Info	[176], [177], [178]
D0565		Empagliflozin	C23H27ClO7	11949646	Moderate		Inter Info	[176], [177], [178]
D0809		Insulin degludec	C274H411N65O81S6	118984462	Moderate		Inter Info	[176], [177], [178]
D0930		Linagliptin	C25H28N8O2	10096344	Moderate		Inter Info	[176], [177], [178]
D0941		Lixisenatide	C215H347N61O65S	90472060	Moderate		Inter Info	[176], [177], [178]
D1294		Pioglitazone	C19H20N2O3S	4829	Moderate		Inter Info	[176], [177], [178]
D1326		Pramlintide	C171H267N51O53S2	70691388	Moderate		Inter Info	[176], [177], [178]
D1392		Repaglinide	C27H36N2O4	65981	Moderate		Inter Info	[176], [177], [178]
D1429		Rosiglitazone	C18H19N3O3S	77999	Moderate		Inter Info	[176], [177], [178]
D1449		Saxagliptin	C18H25N3O2	11243969	Moderate		Inter Info	[176], [177], [178]
D1477		Sitagliptin	C16H15F6N5O	4369359	Moderate		Inter Info	[176], [177], [178]
D1601		Tolazamide	C14H21N3O3S	5503	Moderate		Inter Info	[176], [177], [178]
D1603		Tolbutamide	C12H18N2O3S	5505	Moderate		Inter Info	[176], [177], [178]
	Antagonize the effect of antihypertensive agents					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1779		Dulaglutide	NA	NA	Moderate		Inter Info	[176], [177], [178]
D1887		Semaglutide	C187H291N45O59	56843331	Moderate		Inter Info	[176], [177], [178]

References
1	Canadian Pharmacists Association.
2	Cerner Multum, Inc. "Australian Product Information.".
3	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
4	Product Information. Signifor (pasireotide). Novartis Pharmaceuticals, East Hanover, NJ.
5	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
6	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
7	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
8	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
9	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
10	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
11	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
12	Maxa JL, Hebeler RF, Adeeko MA "Torsades de pointes following concurrent amiodarone and levofloxacin therapy." Proc (Bayl Univ Med Cent) 19 (2006): 345-6. [PMID: 17106497]
13	Product Information. Betapace (sotalol). Berlex, Richmond, CA.
14	Product Information. Cordarone (amiodarone). Wyeth-Ayerst Laboratories, Philadelphia, PA.
15	Product Information. Norpace (disopyramide). Searle, Skokie, IL.
16	Product Information. Procan SR (procainamide). Parke-Davis, Morris Plains, NJ.
17	Product Information. Quiniglute (quinidine). Berlex, Richmond, CA.
18	Product Information. Vascor (bepridil). McNeil Pharmaceutical, Raritan, NJ.
19	Trujillo TC, Nolan PE "Antiarrhythmic agents - Drug interactions of clinical significance." Drug Safety 23 (2000): 509-32. [PMID: 11144659]
20	Yamreudeewong W, DeBisschop M, Martin L, Lower D "Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs." Drug Saf 26 (2003): 421-38. [PMID: 12688833]
21	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
22	Product Information. Barhemsys (amisulpride). Acacia Pharma, Inc, Indianapolis, IN.
23	Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
24	Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5. [PMID: 11103058]
25	Product Information. Trisenox (arsenic trioxide) Cephalon Inc, West Chester, PA.
26	Harper KM, Knapp DJ, Criswell HE, Breese GR "Vasopressin and alcohol: A multifaceted relationship." Psychopharmacology (Berl) 235 (2018): 3363-79. [PMID: 32936259]
27	Javelot H, El-Hage W, Meyer G, Becker G, Michel B, Hingray C "COVID-19 and (hydroxy)chloroquine-azithromycin combination: should we take the risk for our patients?" Br J Clin Pharmacol Apr 29 (2020): epub ahead of print. [PMID: 32350872]
28	National Institutes of Health (NIH) "Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.".
29	Product Information. Chloroquine Phosphate (chloroquine). West-Ward Pharmaceutical Corporation, Eatontown, NJ.
30	Product Information. Hydroxychloroquine Sulfate (hydroxychloroquine). Prasco Laboratories, Cincinnati, OH.
31	Product Information. Plaquenil (R). (hydroxychloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
32	Roden DM, Harrington RA, Poppas A, Russo AM "Considerations for drug interactions on QTc in exploratory COVID-19 (Coroanvirus disease 2019) treatment." Heart Rhythm Apr 14 (2020): epub ahead of print. [PMID: 32302703]
33	Sacher F, Fauchier L, Boveda S, et.al "Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection." Arch Cardiovasc Dis Apr 24 (2020): epub ahead of print. [PMID: 32354666]
34	Saleh M, Gabriels J, ChangD, et.al "The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection." Circ Arrhythm Electrophysiol Apr 29 (2020): epub ahead of print. [PMID: 32347743]
35	Sapp JL, Alqarawi W, MacIntyre CJ, et.al "Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: A statement from the Canadian Heart Rhythm Society." Can J Cardiol Apr 8 (2020): epub ahead of print. [PMID: 32299753]
36	Smit C, Peeters MYM, van den Anker JN, Knibbe CAJ "Chloroquine for SARS-CoV-2: Implications of its unique pharmacokinetic and safety properties." Clin Pharmacokinet Ar 18 (2020): epub ahead of print. [PMID: 32306288]
37	Bessiere F, Roccia H, Deliniere A, et.al "Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit." JAMA Cardiol May 1 (2020): epub ahead of print. [PMID: 32936266]
38	Borba MGS, Val FFA, Sampaio VS, et.al "Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 1 (SARS-CoV-2) infection: A randomized clinical trial." JAMA Netw Open Apr 1 (2020): epub ahead of print. [PMID: 32330277]
39	Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ "Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)" Mayo Clin Proc Apr 7 (2020): epub ahead of print. [PMID: 32359771]
40	Kapoor A, Pandurangi U, Arora V, et.al "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society." Indian Pacing Electorphysiol J Apr 8 (2020): epub ahead of print. [PMID: 32278018]
41	Mercuro NJ, Yen CF, Shim DJ, et.al "Risk of QT interval prolongation associated with the use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)" JAMA Cardiol May 1:e201834 (2020): epub ahead of print. [PMID: 32936252]
42	mitra RL, Greenstein SA, Epstein lm "An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin Possible benefits of intravenous lidocaine." HeartRythm Case Rep Apr 1 (2020): epub ahead of print. [PMID: 32363145]
43	US Food and Drug Administration "FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF CHLOROQUINE PHOSPHATE SUPPLIED FROM THE STRATEGIC NATIONAL STOCKPILE FOR TREATMENT OF COVID-19 IN CERTAIN HOSPITALIZED PATIENTS. Available from: URL: https://www.fda.gov/media/13653" ([2020, Apr 27]):.
44	US Food and Drug Administration "Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems.".
45	Product Information. Propulsid (cisapride). Janssen Pharmaceutica, Titusville, NJ.
46	Trinkle R "Comment: syncopal episodes associated with cisapride." Ann Pharmacother 33 (1999): 251. [PMID: 10084425]
47	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
48	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
49	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
50	Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
51	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
52	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
53	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
54	Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
55	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
56	Castro VM, Clements CC, Murphy SN, et al. "QT interval and antidepressant use: a cross sectional study of electronic health records." BMJ 346 (2013): f288. [PMID: 23360890]
57	Do A, Noohi S, Elie D, et al. Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry.?Psychosomatics. 2016;57(1):57-63. [PMID: 26633294]
58	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
59	Ansari SR, Chopra N "Gatifloxacin and Prolonged QT Interval." Am J Med Sci 327 (2004): 55-6. [PMID: 14722399]
60	Ball P "Quinolone-induced QT interval prolongation: a not-so-unexpected class effect." J Antimicrob Chemother 45 (2000): 557-9. [PMID: 10797074]
61	Bertino JS Jr, Owens RC Jr, Carnes TD, Iannini PB "Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors." Clin Infect Dis 34 (2002): 861-3. [PMID: 11830802]
62	Dale KM, Lertsburapa K, Kluger J, White CM "Moxifloxacin and torsade de pointes." Ann Pharmacother 41 (2007): 336-40. [PMID: 17284508]
63	Demolis JL, Kubitza D, Tenneze L, Funck-Bretano C "Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects." Clin Pharmacol Ther 68 (2000): 658-66. [PMID: 11180026]
64	Falagas ME, Rafailidis PI, Rosmarakis ES "Arrhythmias associated with fluoroquinolone therapy." Int J Antimicrob Agents 29 (2007): 374-9. [PMID: 17241772]
65	Frothingham R "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy 21 (2001): 1468-72. [PMID: 11765299]
66	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
67	Iannini PB, Circiumaru I "Gatifloxacin-induced QTc prolongation and ventricular tachycardia." Pharmacotherapy 21 (2001): 361-2. [PMID: 11253862]
68	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs." BMJ 322 (2001): 46-7. [PMID: 11141163]
69	Kang J, Wang L, Chen XL, Triggle DJ, Rampe D "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG." Mol Pharmacol 59 (2001): 122-6. [PMID: 11125032]
70	Katritsis D, Camm AJ "Quinolones: cardioprotective or cardiotoxic." Pacing Clin Electrophysiol 26 (2003): 2317-20. [PMID: 14675020]
71	Noel GJ, Natarajan J, Chien S, Hunt TL, Goodman DB, Abels R "Effects of three fluoroquinolones on QT interval in healthy adults after single doses." Clin Pharmacol Ther 73 (2003): 292-303. [PMID: 12709719]
72	Oliphant CM, Green GM "Quinolones: a comprehensive review." Am Fam Physician 65 (2002): 455-64. [PMID: 11858629]
73	Owens RC "QT Prolongation with Antimicrobial Agents : Understanding the Significance." Drugs 64 (2004): 1091-124. [PMID: 15139788]
74	Owens RC "Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes." Pharmacotherapy 21 (2001): 301-19. [PMID: 11253855]
75	Owens RC Jr, Ambrose PG "Torsades de pointes associated with fluoroquinolones." Pharmacotherapy 22 (2002): 663-8 discussion 668-72. [PMID: 12013370]
76	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
77	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
78	Siepmann M, Kirch W "Drug points - Tachycardia associated with moxifloxacin." Br Med J 322 (2001): 23. [PMID: 11141146]
79	Stahlmann R "Clinical toxicological aspects of fluoroquinolones." Toxicol Lett 127 (2002): 269-77. [PMID: 12052667]
80	Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF "Effects of three fluoroquinolones on QT analysis after standard treatment courses." Ann Noninvasive Electrocardiol 11 (2006): 52-6. [PMID: 16472283]
81	White CM, Grant EM, Quintiliani R "Moxifloxacin does increase the corrected QT interval." Clin Infect Dis 33 (2001): 1441-2. [PMID: 11565091]
82	Lode H, Vogel F, Elies W "Grepafloxacin: A review of its safety profile based on clinical trials and postmarketing surveillance." Clin Ther 21 (1999): 61-74. [PMID: 10090425]
83	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
84	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
85	Abernethy DR, Wesche DL, Barbey JT, et al. "Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation." Br J Clin Pharmacol 51 (2001): 231-7. [PMID: 11298069]
86	Giao PT, de Vries PJ "Pharmacokinetic interactions of antimalarial agents." Clin Pharmacokinet 40 (2001): 343-73. [PMID: 11432537]
87	Nosten F, ter Kuile FO, Luxemburger C, et al "Cardiac effects of antimalarial treatment with halofantrine." Lancet 341 (1993): 1054-6. [PMID: 8096959]
88	Product Information. Halfan (halofantrine). GlaxoSmithKline, Philadelphia, PA.
89	Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
90	Sudden death in a traveler following halofantrine administration--Togo, 2000. MMWR Morb Mortal Wkly Rep 50 (2001): 169-70, 179. [PMID: 11393488]
91	Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I, Yonezawa Y "The association between intravenous haloperidol and prolonged QT interval." J Clin Psychopharmacol 21 (2001): 257-61. [PMID: 11386487]
92	Huyse F, van Schijndel RS "Haloperidol and cardiac arrest." Lancet 2 (1988): 568-9. [PMID: 2900948]
93	Metzger E, Friedman R "Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill." J Clin Psychopharmacol 13 (1993): 128-32. [PMID: 8463445]
94	O'Brien JM, Rockwood RP, Suh KI "Haloperidol-induced torsade de pointes." Ann Pharmacother 33 (1999): 1046-9. [PMID: 10534216]
95	Product Information. Haldol (haloperidol). McNeil Pharmaceutical, Raritan, NJ.
96	Wilt JL, Minnema AM, Johnson RF, Rosenblum AM "Torsade de pointes associated with the use of intravenous haloperidol." Ann Intern Med 119 (1993): 391-4. [PMID: 8338292]
97	Product Information. Corvert (ibutilide). Pharmacia and Upjohn, Kalamazoo, MI.
98	Product Information. Exforge HCT (amlodipine/hydrochlorothiazide/valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
99	Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32. [PMID: 7042176]
100	Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7. [PMID: 9583400]
101	Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61. [PMID: 1972557]
102	EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
103	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
104	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
105	Product Information. Zokinvy (lonafarnib). Eiger BioPharmaceuticals, Palo Alto, CA.
106	Product Information. Serentil (mesoridazine) Boehringer-Ingelheim, Ridgefield, CT.
107	Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
108	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
109	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
110	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
111	Goto M, Sato M, Kitzazawa H, et.al "Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation." Intern Med 53 (2014): 1629-31. [PMID: 25088875]
112	Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y "QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine." Cardiology 84 (1994): 9-13. [PMID: 7511988]
113	Jain A, Jenkins MG "Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine." Cathet Cardiovasc Diagn 18 (1989): 255-7. [PMID: 2605630]
114	Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T "Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve." Cathet Cardiovasc Diagn 19 (1990): 229-36. [PMID: 2334953]
115	Nakayama M, Saito A, Kitazawa H, et.al "Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases." Intern Med 51 (2012): 351-6. [PMID: 22333368]
116	Nakayama M, Tanaka N, Sakoda K, et.al "Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease." Circ J 79 (2015): 530-6. [PMID: 25746536]
117	Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML "Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine." J Am Coll Cardiol 15 (1990): 275-8. [PMID: 2299067]
118	Vrolix M, Piessens J, De Geest H "Torsades de pointes after intracoronary papaverine." Eur Heart J 12 (1991): 273-6. [PMID: 2044564]
119	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
120	Product Information. Detectnet (copper cu 64 dotatate). Currax Pharmaceuticals LLC, Morristown, NJ.
121	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
122	Mittal SR "Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine." J Assoc Physicians India 62 (2014): 426-7. [PMID: 25438492]
123	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
124	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
125	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
126	Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
127	Product Information. Olinvyk (oliceridine). Trevena Inc, Chesterbrook, PA.
128	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
129	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
130	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
131	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
132	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
133	Product Information. Definity (perflutren). Lantheus Medical Imaging Inc, North Billerica, MA.
134	Product Information. Optison (perflutren). Mallinckrodt Medical Inc, St. Louis, MO.
135	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
136	Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75. [PMID: 9186877]
137	Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9. [PMID: 2178522]
138	Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33. [PMID: 7885977]
139	Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24. [PMID: 12796155]
140	Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6. [PMID: 3168573]
141	Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6. [PMID: 7446635]
142	Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9. [PMID: 708661]
143	Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5. [PMID: 7197475]
144	Hypokalaemia due to salbutamol overdosage. Br Med J (Clin Res Ed) 283 (1981): 500-1. [PMID: 6114774]
145	Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20. [PMID: 3956296]
146	Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51. [PMID: 11410561]
147	Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90. [PMID: 16750469]
148	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
149	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
150	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
151	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
152	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
153	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.
154	Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9. [PMID: 19514]
155	Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5. [PMID: 9581741]
156	Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9. [PMID: 7988180]
157	Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71. [PMID: 3545273]
158	Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9. [PMID: 1978872]
159	Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9. [PMID: 921062]
160	Anson BD, Weaver JG, Ackerman MJ, et al. "Blockade of HERG channels by HIV protease inhibitors." Lancet 365 (2005): 682-686. [PMID: 15721475]
161	Biondi L "Health Canada endorsed important safety information on Invirase (saquinavir mesylate)." .
162	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
163	FDA. U.S. Food and Drug Administration "FDA drug safety communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms.".
164	Demolis JL, Charransol A, Funck-Brentano C, Jaillon P "Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers." Br J Clin Pharmacol 41 (1996): 499-503. [PMID: 8799513]
165	Dupont H, Timsit JF, Souweine B, Gachot B, Wolff M, Regnier B "Torsades de pointe probably related to sparfloxacin." Eur J Clin Microbiol Infect Dis 15 (1996): 350-1. [PMID: 8781892]
166	Jaillon P, Morganroth J, Brumpt I, Talbot G "Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group." J Antimicrob Chemother 37(suppl a) (1996): 161-7. [PMID: 8737135]
167	Lipsky BA, Dorr MB, Magner DJ, Talbot GH "Safety profile of sparfloxacin, a new fluoroquinolone antibiotic." Clin Ther 21 (1999): 148-59. [PMID: 10090432]
168	Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
169	Zix JA, GeerdesFenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
170	Fletcher GF, Kazamias TM "Cardiotoxic effects of Mellaril: conduction disturbances and supraventricular arrhythmias." Am Heart J 78 (1969): 135-8. [PMID: 5794785]
171	Hartigan-Go K, Bateman DN, Nyberg G, Martensson E, Thomas SHL "Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans." Clin Pharmacol Ther 60 (1996): 543-53. [PMID: 8941027]
172	Liberatore MA, Robinson DS "Torsade de pointes: a mechanism for sudden death associated with neuroleptic drug therapy?" J Clin Psychopharmacol 4 (1984): 143-6. [PMID: 6145728]
173	Product Information. Mellaril (thioridazine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
174	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
175	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
176	Product Information. Sandostatin (octreotide). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
177	Product Information. Somatuline Depot (lanreotide). Ipsen Inc, Milford, MA.
178	Williams G, Fuessl HS, Burrin JM, Chilvers E, Bloom SR "Postprandial glycaemic effects of a long-acting somatostatin analogue (octreotide) in non-insulin diabetes mellitus." Horm Metab Res 20 (1988): 168-70. [PMID: 2898427]
179	Product Information. Exelon (rivastigmine) Novartis Pharmaceuticals, East Hanover, NJ.
180	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
181	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
182	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
183	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
184	Kane JM, Carson WH, Saha AR, et al. "Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder." J Clin Psychiatry 63 (2002): 763-71. [PMID: 12363115]
185	Keck PE Jr, Marcus R, Tourkodimitris S, et al. "A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania." Am J Psychiatry 160 (2003): 1651-8. [PMID: 12944341]
186	Nelson S, Leung JG "Torsades de Pointes After Administration of Low-Dose Aripiprazole (February)." Ann Pharmacother (2013):. [PMID: 23362038]
187	Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG "Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study." J Clin Psychiatry 64 (2003): 1048-56. [PMID: 14628980]
188	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
189	Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
190	Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
191	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
192	Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
193	Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
194	Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
195	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
196	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
197	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
198	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
199	Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
200	Flogstad AK, Halse J, Grass P, Abisch E, Djoseland O, Kutz K, Bodd E, Jervell J, Flgstad AK, Djseland O "A comparison of octreotide, bromocriptine, or a combination of both drugs in acromegaly." J Clin Endocrinol Metab 79 (1994): 461-5. [PMID: 8045964]
201	Product Information. Parlodel (bromocriptine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
202	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
203	Landgraf R, Landgraf-Leurs MM, Nusser J, et al "Effect of somatostatin analogue (SMS201-995) on cyclosporine levels." Transplantation 44 (1987): 724-5. [PMID: 2891211]
204	Product Information. Neoral Oral Solution (cyclosporine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
205	Ausband SC, Goodman PE "An unusual case of clarithromycin associated ergotism." J Emerg Med 4 (2001): 411-3. [PMID: 11728770]
206	Baldwin ZK, Ceraldi CC "Ergotism associated with HIV antiviral protease inhibitor therapy." J Vasc Surg 37 (2003): 676-8. [PMID: 12618710]
207	Bird PA, Sturgess AD "Clinical ergotism with severe bilateral upper limb ischaemia precipitated by an erythromycin - ergotamine drug interaction." Aust N Z J Med 30 (2000): 635-6. [PMID: 11108077]
208	Blanche P, Rigolet A, Gombert B, Ginsburg C, Salmon D, Sicard D "Ergotism related to a single dose of ergotamine tartrate in an AIDS patient treated with ritonavir." Postgrad Med J 75 (1999): 546-7. [PMID: 10616689]
209	Caballero-Granado FJ, Viciana P, Cordero E, Gomez-Vera MJ, del Nozal M, Lopez-Cortes LF "Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient." Antimicrob Agents Chemother 41 (1997): 1207. [PMID: 9145904]
210	Dresser GK, Spence JD, Bailey DG "Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition." Clin Pharmacokinet 38 (2000): 41-57. [PMID: 10668858]
211	Eadie MJ "Clinically significant drug interactions with agents specific for migraine attacks." Cns Drugs 15 (2001): 105-18. [PMID: 11460889]
212	Francis H, Tyndall A, Webb J "Severe vascular spasm due to erythromycin-ergotamine interaction." Clin Rheumatol 3 (1984): 243-6. [PMID: 6236021]
213	Hayton AC "Precipitation of acute ergotism by triacetyloleandomycin." N Z Med J 69 (1969): 42. [PMID: 5304704]
214	Horowitz RS, Dart RC, Gomez HF "Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction." Arch Intern Med 156 (1996): 456-8. [PMID: 8607732]
215	Leroy F, Asseman P, Pruvost P, Adnet P, Lacroix D, Thery C "Dihydroergotamine-erythromycin-induced ergotism." Ann Intern Med 109 (1988): 249. [PMID: 3389610]
216	Liaudet L "Severe ergotism associated with interaction between ritonavir and ergotamine." BMJ 318 (1999): 771. [PMID: 10082701]
217	Liaudet L, Buclin T, Jaccard C, Eckert P "Severe ergotism associated with interaction between ritonavir and ergotamine." Br Med J 318 (1999): 771. [PMID: 10082701]
218	Matthews NT, Havill JH "Ergotism with therapeutic doses of ergotamine tartrate." N Z Med J 89 (1979): 476-7. [PMID: 314074]
219	Montero A, Giovannoni AG, Tvrde PL "Leg ischemia in a patient receiving ritonavir and ergotamine." Ann Intern Med 130 (1999): 329. [PMID: 10068398]
220	Mortier E, Pouchet J, Vinceneux P, Lalande M "Ergotism related to interaction between nelfinavir and ergotamine." Am J Med 110 (2001): 594. [PMID: 11347624]
221	Product Information. Cafergot (caffeine-ergotamine). Novartis Pharmaceuticals, East Hanover, NJ.
222	Product Information. D.H.E. 45 (dihydroergotamine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
223	Product Information. Migranal (dihydroergotamine nasal). Novartis Pharmaceuticals, East Hanover, NJ.
224	Rosenthal E, Sala F, Chichmanian RM, Batt M, Cassuto JP "Ergotism related to concurrent administration of ergotamine tartrate and indinavir." JAMA 281 (1999): 987. [PMID: 10086430]
225	Spiegel M, Schmidauer C, Kampfl A, Sarcletti M, Poewe W "Cerebral ergotism under treatment with ergotamine and ritonavir." Neurology 57 (2001): 743-4. [PMID: 11524501]
226	Srisuma S, Lavonas EJ, Wananukul W "Ergotism and factitious hypotension associated with interaction of ergotamine with CYP3A4 inhibitors." Clin Toxicol (Phila) (2014): 1-4. [PMID: 24978905]
227	Tribble MA, Gregg CR, Margolis DM, Amirkhan R, Smith JW "Fatal ergotism induced by an HIV protease inhibitor." Headache 42 (2002): 694-5. [PMID: 12482227]
228	Vila A, Mykietiuk A, Bonvehi P, Temporiti E, Uruena A, Herrera F "Clinical ergotism induced by ritonavir." Scand J Infect Dis 33 (2001): 788-9. [PMID: 11728055]
229	Ghali R, De Lean J, Douville Y, Noel HP, Labbe R "Erythromycin-associated ergotamine intoxication: arteriographic and electrophysiologic analysis of a rare cause of severe ischemia of the lower extremities and associated ischemic neuropathy." Ann Vasc Surg 7 (1993): 291-6. [PMID: 8391300]
230	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
231	Product Information. Razadyne (galantamine). Johnson and Johnson Medical Inc, Arlington, TX.
232	Product Information. Afinitor (everolimus). Novartis Pharmaceuticals, East Hanover, NJ.
233	Product Information. Qelbree (viloxazine). Supernus Pharmaceuticals Inc, Rockville, MD.
234	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
235	Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
236	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
237	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
238	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
239	Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
240	Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
241	Schaefer DC, Cheskin LJ "Constipation in the elderly." Am Fam Physician 58 (1998): 907-14. [PMID: 9767726]
242	Eggleston W, Clark KH, Marraffa JM "Loperamide abuse associated with cardiac dysrhythmia and death." Ann Emerg Med 69 (2017): 83-6. [PMID: 27140747]
243	US Food and Drug Administration "FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse.".
244	Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
245	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
246	Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.
247	Product Information. OxyContin (oxycodone). Purdue Frederick Company, Norwalk, CT.
248	Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
249	Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
250	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
251	Product Information. Netspot (dotatate). Advanced Accelerator Applications, New York, NY.
252	Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
253	Product Information. Imbruvica (ibrutinib). Pharmacyclics Inc, Sunnyvale, CA.
254	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
255	Product Information. Nourianz (istradefylline). Kyowa Kirin, Inc, Bedminster, NJ.
256	Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
257	Product Information. Lorbrena (lorlatinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
258	Product Information. Latuda (lurasidone). Sunovion Pharmaceuticals Inc, Marlborough, MA.
259	Product Information. Zepzelca (lurbinectedin). Jazz Pharmaceuticals, Palo Alto, CA.
260	Product Information. Lutathera (lutetium Lu 177 dotatate). Advanced Accelerator Applications, New York, NY.
261	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
262	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
263	Product Information. Gavreto (pralsetinib). Blueprint Medicines Corporation, Cambridge, MA.
264	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
265	Gilead Sciences, Inc "About Remdesivir.".
266	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
267	Product Information. Qinlock (ripretinib). Deciphera Pharmaceuticals, Waltham, MA.
268	Product Information. Rinvoq (upadacitinib). AbbVie US LLC, North Chicago, IL.
269	Hanci V, Aydin M, Yurtlu BS, et.al "Anesthesia induction with sevoflurane and propofol: evaluation of P-wave dispersion, QT and corrected QT intervals." Kaohsiung J Med Sci 26 (2010): 470-7. [PMID: 20837343]
270	Kim DH, Kweon TD, Nam SB, Han DW, Cho WY, Lee JS "Effects of target concentration infusion of propofol and tracheal intubation on QTc interval." Anaesthesia 63 (2008): 1061-4. [PMID: 18717665]
271	Kleinsasser A, Kuenszberg E, Loeckinger A, et.al "Sevoflurane, but not propofol, significantly prolongs the Q-T interval." Anesth Analg 90 (2000): 25-7. [PMID: 10624970]
272	Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F "Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol." Anaesthesia 56 (2001): 248-50. [PMID: 11251432]
273	Paventi S, Santevecchi A, Ranieri R "Effects of sevoflurane versus propofol on QT interval." Minerva Anestesiol 67 (2001): 637-40. [PMID: 11731753]
274	Scalese MJ, Herring HR, Rathburn RC, Skrepnek GH, Ripley TL "Propofol-associated QTc prolongation." Ther Adv Drug Saf 7 (2016): 68-78. [PMID: 27298717]
275	Staikou C, Stamelos M, Stavroulakis E "Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity." Br J Anaesth 112 (2014): 217-30. [PMID: 24305646]
276	Toyoda T, Terao Y, Oji M, Okada M, Fukusaki M, Sumikawa K "The interaction of antiemetic dose of droperidol with propofol on QT interval during anesthetic induction." J Anesth 27 (2013): 885-9. [PMID: 23660990]
277	Whyte SD, Booker PD, Buckley DG "The Effects of Propofol and Sevoflurane on the QT Interval and Transmural Dispersion of Repolarization in Children." Anesth Analg 100 (2005): 71-77. [PMID: 15616054]
278	Wutzler A, De Asmundis C, Matsuda H, et.al "Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults." J Electrocardiol 51 (2018): 170-4. [PMID: 29174097]
279	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
280	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
281	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
282	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
283	Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F "QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone." Pacing Clin Electrophysiol 28 (2005): 472-3. [PMID: 15869686]
284	Product Information. Flagyl (metronidazole). Searle, Skokie, IL.
285	Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN). Aptalis Pharma, Birmingham, AL.
286	Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
287	Product Information. Pifeltro (doravirine). Merck & Company Inc, Whitehouse Station, NJ.
288	Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]
289	Darpo B "Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes." Eur Heart J Suppl 3(Suppl K) (2001): K70-80.
290	Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T "QT prolongation and torsades de pointes after administration of trimethoprin-sulfamethoxazole." Am J Cardiol 59 (1987): 376-7. [PMID: 3492908]
291	Wiener I, Rubin D, Martinez E, et al "QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration." Mt Sinai J Med 48 (1981): 53-5. [PMID: 6970886]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence